INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 112 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346,555 | -83.0% | 10,960 | -78.1% | 0.00% | -83.3% |
| Q2 2023 | $2,042,179 | +47.2% | 50,078 | +34.5% | 0.02% | +38.5% |
| Q1 2023 | $1,387,447 | +12.7% | 37,227 | +69.4% | 0.01% | +30.0% |
| Q3 2022 | $1,231,000 | -47.0% | 21,970 | -51.1% | 0.01% | -56.5% |
| Q2 2022 | $2,324,000 | +33.9% | 44,900 | +87.9% | 0.02% | +43.8% |
| Q1 2022 | $1,736,000 | -54.6% | 23,900 | +1.3% | 0.02% | -61.0% |
| Q2 2021 | $3,822,000 | +120.4% | 23,600 | -26.0% | 0.04% | +78.3% |
| Q4 2020 | $1,734,000 | +688.2% | 31,880 | +179.1% | 0.02% | +27.8% |
| Q4 2017 | $220,000 | -1.3% | 11,424 | +9.4% | 0.02% | -64.0% |
| Q2 2016 | $223,000 | – | 10,443 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |